35.64

0.06% 0.02

After Hours: 35.78 0.14 +0.39%

Collegium Pharmaceutical Inc (COLL)

Overview News Price History Option Chain Financials Discussions Forecast

Collegium Pharmaceutical Inc stock is traded at $35.64, with a volume of 512.30K. It is up +0.06% in the last 24 hours and up +3.30% over the past month. Collegium Pharmaceutical Inc is a diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The company has developed, licensed, and acquired a portfolio of meaningfully differentiated products for the treatment of attention deficit hyperactivity disorder (ADHD) and moderate to severe pain. It commercializes its products in the United States, including Jornay PM, Belbuca, Xtampza ER, Nucynta ER, Nucynta IR (collectively, the Nucynta Products), and Symproic. The company's product portfolio includes Jornay PM, Belbuca, Xtampza ER, Nucynta IR, Nucynta ER, and Symproic.

Previous Close:

$35.62

Open:

$35.62

24h Volume:

512.30K

Relative Volume:

1.00

Market Cap:

$1.15B

Revenue:

$780.57M

Net Income/Loss:

$62.87M

P/E Ratio:

20.76

EPS:

1.7171

Net Cash Flow:

$327.58M

1W Performance:

+8.79%

1M Performance:

+3.30%

6M Performance:

+10.79%

1Y Performance:

+33.33%

1-Day Range:

$35.35

$36.27

1-Week Range:

$33.06

$36.27

52-Week Range:

$25.86

$50.79

Collegium Pharmaceutical Inc Stock (COLL) Company Profile

Name

Collegium Pharmaceutical Inc

Sector

Healthcare (1110)

Industry

Drug Manufacturers - Specialty & Generic (83)

Phone

781-713-3699

Address

100 TECHNOLOGY CENTER DRIVE, STOUGHTON, MA

Employee

423

Twitter

Next Earnings Date

2024-11-07

Latest SEC Filings

COLL's Discussions on Twitter

Compare COLL vs TAK, ZTS, HLN, TEVA, UTHR

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
COLL Collegium Pharmaceutical Inc	35.64	1.15B	780.57M	62.87M	327.58M	1.7171
TAK Takeda Pharmaceutical Co Adr	17.85	57.12B	29.85B	776.90M	4.35B	0.2408
ZTS Zoetis Inc	121.11	49.56B	9.47B	2.67B	2.28B	6.0218
HLN Haleon Plc Adr	9.70	43.86B	14.54B	2.22B	2.58B	0.4871
TEVA Teva Pharmaceutical Industries Ltd Adr	31.77	35.89B	17.41B	1.43B	1.00B	1.2182
UTHR United Therapeutics Corp	578.54	25.06B	3.18B	1.33B	1.04B	27.90

Collegium Pharmaceutical Inc Stock (COLL) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-09-25	Initiated	Barclays	Overweight
Jan-10-25	Upgrade	Needham	Hold → Buy
Jul-30-24	Upgrade	H.C. Wainwright	Neutral → Buy
Jun-07-24	Upgrade	Jefferies	Hold → Buy
May-10-24	Downgrade	Needham	Buy → Hold
May-10-24	Downgrade	Piper Sandler	Overweight → Neutral
Jan-04-24	Downgrade	Jefferies	Buy → Hold
Aug-25-23	Reiterated	Needham	Buy
May-02-23	Resumed	Jefferies	Buy
Aug-08-22	Downgrade	H.C. Wainwright	Buy → Neutral
Feb-15-22	Upgrade	Cantor Fitzgerald	Neutral → Overweight
Aug-06-21	Downgrade	Cantor Fitzgerald	Overweight → Neutral
Jan-11-21	Reiterated	H.C. Wainwright	Buy
Jul-14-20	Initiated	BWS Financial	Sell
May-27-20	Initiated	Guggenheim	Neutral
Feb-19-20	Resumed	Jefferies	Buy
Oct-30-19	Reiterated	Needham	Buy
May-03-19	Resumed	H.C. Wainwright	Buy
Apr-12-19	Resumed	Janney	Buy
Mar-20-19	Initiated	SunTrust	Hold
Jan-16-19	Reiterated	Needham	Buy
Mar-08-18	Reiterated	H.C. Wainwright	Buy
Feb-07-18	Reiterated	Needham	Buy
Dec-05-17	Reiterated	Needham	Buy
Sep-11-17	Initiated	H.C. Wainwright	Buy
May-11-17	Reiterated	Needham	Buy
Sep-13-16	Initiated	Gabelli & Co	Buy
Jun-01-15	Initiated	Jefferies	Buy
Jun-01-15	Initiated	Needham	Buy
Jun-01-15	Initiated	Piper Jaffray	Overweight

View All

Collegium Pharmaceutical Inc Stock (COLL) Latest News

Apr 14, 2026

Is Collegium Pharmaceutical (COLL) one of the best small-cap drug manufacturers? - MSN

Apr 14, 2026

Apr 13, 2026

Aug Technicals: Does Collegium Pharmaceutical Inc offer margin of safetyGlobal Markets & Daily Chart Pattern Signals - baoquankhu1.vn

Apr 13, 2026

Apr 12, 2026

Collegium Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Officer Smith Thomas B - Moomoo

Apr 12, 2026

Apr 11, 2026

How The Collegium Pharmaceutical (COLL) Narrative Is Evolving On A Modest Target Price Shift - Yahoo Finance

Apr 11, 2026

Assessing Collegium Pharmaceutical (COLL) Valuation After Mixed Recent Share Price Performance - Sahm

Apr 11, 2026

Apr 10, 2026

Chipmakers Recap: What is the target price for Collegium Pharmaceutical Inc stockGDP Growth & Fast Exit Strategy with Risk Control - baoquankhu1.vn

Apr 10, 2026

Sectors Review: Does Collegium Pharmaceutical Inc offer margin of safetyBreakout Watch & Advanced Technical Signal Analysis - baoquankhu1.vn

Apr 10, 2026

Apr 09, 2026

COLL SEC FilingsCollegium Pharmaceutical Inc 10-K, 10-Q, 8-K Forms - Stock Titan

Apr 09, 2026

Precision Trading with Collegium Pharmaceutical Inc. (COLL) Risk Zones - Stock Traders Daily

Apr 09, 2026

Apr 08, 2026

Q4 Earnings Highs And Lows: Pfizer (NYSE:PFE) Vs The Rest Of The Branded Pharmaceuticals Stocks - TradingView — Track All Markets

Apr 08, 2026

Collegium to Participate in Upcoming Investor Conferences - Bitget

Apr 08, 2026